Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection
Author(s) -
Katja Merches,
Vishal Khairnar,
Torben Knuschke,
Namir Shaabani,
Nadine Honke,
Vikas Duhan,
Mike Recher,
Alexander A. Navarini,
Cornelia Hardt,
Dieter Häussinger,
Burkhard Tümmler,
Erich Gulbins,
Anthony H. Futerman,
Daniel Hoffmann,
Florian Läng,
Philipp A. Lang,
Astrid M. Westendorf,
Karl S. Lang
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430200
Subject(s) - pseudomonas aeruginosa , microbiology and biotechnology , virus , interferon , biology , viremia , virology , neutropenia , lymphocytic choriomeningitis , virulence , lysozyme , immunology , bacteria , immune system , gene , cd8 , chemotherapy , biochemistry , genetics
Type I interferon (IFN-I) predisposes to bacterial superinfections, an important problem during viral infection or treatment with interferon-alpha (IFN-α). IFN-I-induced neutropenia is one reason for the impaired bacterial control; however there is evidence that more frequent bacterial infections during IFN-α-treatment occur independently of neutropenia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom